| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $194.5M | — | +66.8% |
| Cost of Revenue | $9.9M | — | +276.6% |
| R&D Expense | $126.6M | — | +13.6% |
| SG&A Expense | $163.9M | — | +54.1% |
| Operating Income | -$106.0M | — | -1.5% |
| Net Income | -$166.6M | — | +1.8% |
| EPS (Basic) | -$0.84 | — | +4.5% |
| EPS (Diluted) | -$0.84 | — | +4.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $879.9M | +54.3% | +62.8% |
| Accounts Receivable | $205.2M | +47.2% | +78.0% |
| Inventory | $33.0M | +23.3% | +734.1% |
| Current Assets | $1.24B | +55.6% | +78.6% |
| Total Assets | $1.37B | +46.5% | +55.5% |
| Current Liabilities | $816.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$197.3M | — | +1.0% |
| Capital Expenditures | $69K | — | — |
| Investing Cash Flow | -$42.7M | — | -2579.3% |
| Financing Cash Flow | $549.9M | — | +811.5% |
| Free Cash Flow | -$197.3M | — | +0.9% |
| +436.7% |
| Long-term Debt | $2.65B | +32.2% | — |
| Total Liabilities | $3.64B | +20.8% | +44.4% |
| Stockholders' Equity | -$2.28B | -9.2% | -38.2% |